- Home
- AMRN vs XBIT Comparison
AMRN vs XBIT Comparison
Compare AMRN & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$14.03
HOLD
Current Price
$2.51
Company Overview
Basic Information| Metric | AMRN | XBIT |
|---|---|---|
| Founded | 1989 | 2005 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 73.2M |
| IPO Year | 1993 | 2015 |
Fundamental Metrics
Financial Performance| Metric | AMRN | XBIT |
|---|---|---|
| Price | $14.03 | $2.51 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 95.3K | 48.6K |
| Earning Date | 10-29-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $226,733,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.08 | $2.09 |
| 52 Week High | $20.90 | $4.67 |
Technical Indicators
Market Signals| Indicator | AMRN | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 46.03 | 54.13 |
| Support Level | $13.12 | $2.40 |
| Resistance Level | $14.33 | $2.55 |
| Average True Range (ATR) | 0.61 | 0.09 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 71.53 | 80.77 |
Price Performance
Historical Comparison AMRN
XBIT
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.